Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 172,000 | 167,824 | 164,502 | 156,240 | 155,552 |
| Cost of Goods | 94,743 | 92,944 | 92,008 | 90,771 | 87,964 |
| Gross Profit | 77,257 | 74,880 | 72,494 | 65,469 | 67,588 |
| Operating Expenses | 96,401 | 97,021 | 94,443 | 96,807 | 87,126 |
| Operating Income | -18,401 | -21,197 | -21,941 | -30,567 | -18,574 |
| Interest Expense | 1,624 | 1,642 | 1,666 | 1,685 | 1,681 |
| Other Income | 3,897 | 4,990 | 4,590 | 4,571 | 4,969 |
| Pre-tax Income | -16,128 | -17,849 | -19,017 | -27,681 | -15,286 |
| Income Tax | -804 | -150 | -375 | -620 | -960 |
| Net Income Continuous | -15,324 | -17,699 | -18,642 | -27,061 | -14,326 |
| Net Income | $-15,324 | $-17,699 | $-18,642 | $-27,061 | $-14,326 |
| EPS Basic Total Ops | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 |
| EPS Basic Continuous Ops | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 |
| EPS Diluted Total Ops | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 |
| EPS Diluted Continuous Ops | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.04 | N/A | N/A |
| EBITDA(a) | $519 | $-2,482 | $-3,107 | $-11,575 | $509 |